Neuroblastoma

• CLINICAL_TRIALS trial_result · 2008-06-03
  Clinical Trial Update: Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma [Phase 1]

  A Phase 1 clinical trial evaluating gene-modified allogeneic neuroblastoma cells for relapsed or refractory neuroblastoma has completed.

• CLINICAL_TRIALS trial_result · 2008-04-10
  Clinical Trial Update: Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy [Phase 1, Phase 2]

  Phase 1/2 study evaluating recombinant human thrombopoietin as supportive care for children receiving ifosfamide, carboplatin, and etoposide…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' Tumor [Phase 2]

  Phase II trial evaluating the combination of all-trans-retinoic acid and interferon-alpha-2a in children with recurrent neuroblastoma or Wil…

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma [Phase 2]

  This is a Phase 2 clinical trial update from the National Cancer Institute evaluating new therapeutic strategies for Ewing's sarcoma family …

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy [Phase 1]

  Phase I pharmacokinetic trial of phenylbutyrate given as a continuous infusion in pediatric patients with refractory malignancies has comple…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2006-09-08
  Clinical Trial Update: Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse [Phase 2]

  A Phase 2 trial of vinorelbine and cyclophosphamide in patients with refractory or relapsed tumors, including rhabdomyosarcoma, Ewing sarcom…